Reply to S. Hapani et al
Publication
, Journal Article
Lyman, GH; Hurwitz, HI; Sirzén, F; Rohr, UP
Published in: Journal of Clinical Oncology
September 1, 2011
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
September 1, 2011
Volume
29
Issue
25
Start / End Page
3490 / 3491
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Hurwitz, H. I., Sirzén, F., & Rohr, U. P. (2011). Reply to S. Hapani et al. Journal of Clinical Oncology, 29(25), 3490–3491. https://doi.org/10.1200/JCO.2011.36.5692
Lyman, G. H., H. I. Hurwitz, F. Sirzén, and U. P. Rohr. “Reply to S. Hapani et al.” Journal of Clinical Oncology 29, no. 25 (September 1, 2011): 3490–91. https://doi.org/10.1200/JCO.2011.36.5692.
Lyman GH, Hurwitz HI, Sirzén F, Rohr UP. Reply to S. Hapani et al. Journal of Clinical Oncology. 2011 Sep 1;29(25):3490–1.
Lyman, G. H., et al. “Reply to S. Hapani et al.” Journal of Clinical Oncology, vol. 29, no. 25, Sept. 2011, pp. 3490–91. Scopus, doi:10.1200/JCO.2011.36.5692.
Lyman GH, Hurwitz HI, Sirzén F, Rohr UP. Reply to S. Hapani et al. Journal of Clinical Oncology. 2011 Sep 1;29(25):3490–3491.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
September 1, 2011
Volume
29
Issue
25
Start / End Page
3490 / 3491
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences